U.S. markets closed
  • S&P Futures

    4,564.75
    -11.00 (-0.24%)
     
  • Dow Futures

    34,567.00
    -55.00 (-0.16%)
     
  • Nasdaq Futures

    15,940.25
    -48.25 (-0.30%)
     
  • Russell 2000 Futures

    2,195.70
    -9.50 (-0.43%)
     
  • Crude Oil

    66.65
    +0.15 (+0.23%)
     
  • Gold

    1,768.80
    +6.10 (+0.35%)
     
  • Silver

    22.41
    +0.13 (+0.58%)
     
  • EUR/USD

    1.1297
    -0.0009 (-0.08%)
     
  • 10-Yr Bond

    1.4480
    +0.0140 (+0.98%)
     
  • Vix

    27.95
    -3.17 (-10.19%)
     
  • GBP/USD

    1.3286
    -0.0016 (-0.12%)
     
  • USD/JPY

    113.1100
    -0.0990 (-0.09%)
     
  • BTC-USD

    56,570.05
    -704.41 (-1.23%)
     
  • CMC Crypto 200

    1,439.18
    +0.29 (+0.02%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,777.28
    +23.91 (+0.09%)
     

BioMarin to Participate in Three Upcoming Virtual Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

- Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 1:15pm ET

- BofA Global Healthcare Conference 2021 on September 17 at 12:35pm ET/5:35pm BST

- J.P. Morgan 12th Annual U.S. All Stars Conference on September 22 at 12:00pm ET/5:00pm BST

SAN RAFAEL, Calif., Aug. 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)
BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-upcoming-virtual-investor-conferences-301362189.html

SOURCE BioMarin Pharmaceutical Inc.